| Literature DB >> 29760533 |
Tim Rollenske1,2, Valeria Szijarto3, Jolanta Lukasiewicz4, Luis M Guachalla3, Katarina Stojkovic4, Katharina Hartl3, Lukas Stulik3, Simone Kocher2, Felix Lasitschka5, Mohammed Al-Saeedi6, Jutta Schröder-Braunstein7, Moritz von Frankenberg8, Gereon Gaebelein9,10, Peter Hoffmann11, Sabrina Klein12, Klaus Heeg12, Eszter Nagy3, Gabor Nagy3, Hedda Wardemann13,14.
Abstract
Humoral immune responses to microbial polysaccharide surface antigens can prevent bacterial infection but are typically strain specific and fail to mediate broad protection against different serotypes. Here we describe a panel of affinity-matured monoclonal human antibodies from peripheral blood immunoglobulin M-positive (IgM+) and IgA+ memory B cells and clonally related intestinal plasmablasts, directed against the lipopolysaccharide (LPS) O-antigen of Klebsiella pneumoniae, an opportunistic pathogen and major cause of antibiotic-resistant nosocomial infections. The antibodies showed distinct patterns of in vivo cross-specificity and protection against different clinically relevant K. pneumoniae serotypes. However, cross-specificity was not limited to K. pneumoniae, as K. pneumoniae-specific antibodies recognized diverse intestinal microbes and neutralized not only K. pneumoniae LPS but also non-K. pneumoniae LPS. Our data suggest that the recognition of minimal glycan epitopes abundantly expressed on microbial surfaces might serve as an efficient humoral immunological mechanism to control invading pathogens and the large diversity of the human microbiota with a limited set of cross-specific antibodies.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29760533 DOI: 10.1038/s41590-018-0106-2
Source DB: PubMed Journal: Nat Immunol ISSN: 1529-2908 Impact factor: 25.606